Analyst Ratings for Immunocore Hldgs
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on Immunocore Hldgs (NASDAQ:IMCR) stock, with 6 bullish and 1 somewhat bullish. The average 12-month price target is $82.57, up 17.96% from the previous average of $70.
June 12, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunocore Hldgs (NASDAQ:IMCR) has received 6 bullish and 1 somewhat bullish ratings from 7 analysts in the past 3 months. The average 12-month price target is $82.57, up 17.96% from the previous average.
The majority of analysts have a bullish outlook on Immunocore Hldgs, with 6 out of 7 analysts giving a positive rating. The average 12-month price target has increased by 17.96% from the previous average, indicating a positive sentiment towards the stock. This is likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100